Lettuce from Salinas part of Dole product recalled for E. coli contamination

Dole Fresh Vegetables president Eric Schwartz has confirmed that the romaine and green leaf lettuce in its Hearts Delight salad mix was produced locally in the Salinas Valley and mixed with butter lettuce from Ohio and romaine from growers in Colorado.

The lettuces were processed at Dole's plant in Springfield, Ohio, on Sept. 6, said Schwartz. Eighty-eight cases — or 528 bags — were distributed in Canada and 755 cases containing 4,530 bags in the U.S.

The U.S. Food and Drug Administration and Dole Food Co, the parent company of Dole Fresh Vegetables, issued a voluntary recall Monday, one day after the Canadian Food Inspection Agency issued its own advisory in Canada.

Dole did confirm that the lettuce products had been shipped to several provinces in Canada as well as to Illinois, Indiana, Maine, Michigan, Mississippi, New York, Ohio, Pennsylvania and Tennessee.

 

Fresh and risky

Right on the heels of the nationwide E. coli outbreak stemming from tainted lettuce, the US FDA has announced a nationwide warning to consumers against consuming spinach for the same reasons.

Douglas Powell and Ben Chapman of the Food Safety Network say that despite the fact that fruits and vegetables are good for us, they are one of, if not the most, significant source of foodborne illness today in North America, with an estimated 76 million illness and 5,000 deaths in the U.S. each and every year from foodborne illness.

The U.S. lettuce/leafy greens industry took the first step in doing this, releasing a comprehensive set of food safety guidelines, from the farm through to retail, in April, 2006.

Powell and Chapman state that any grower can clean up for a once-a-year audit by inspectors. They are urging growers to maintain the standards for the rest of the year as well.
 

Dole sued by Oregon E. coli victim

An E. coli lawsuit was filed against Dole late Thursday in United States District Court for the District of Oregon.  The lawsuit was filed on behalf of Gwyn Wellborn, a Salem, Oregon woman who became ill with an E. coli O157:H7 infection after eating Dole brand baby spinach.  Ms. Wellborn and her husband, David, are represented by Marler Clark, the Seattle law firm that has represented hundreds of victims E. coli outbreaks, including victims of last fall’s E. coli outbreak traced to Dole brand lettuce.


The lawsuit alleges that Mrs. Wellborn purchased Dole brand baby spinach on August 21, 2006 and consumed the spinach in salads over several days during the week of August 21 through August 25.  Ms. Wellborn became ill with symptoms of E. coli O157:H7 infection, including diarrhea and stomach cramping, on August 25.  Her symptoms continued to worsen, and Mr. Wellborn took his wife to the emergency room at Salem Hospital in the early morning hours of August 27.  Ms. Wellborn was treated and released, but was admitted to Salem Hospital after a second visit to the emergency room at midday on the 27th.  She remained hospitalized at Salem Hospital for six days, and was transferred to Oregon Health Sciences University (OHSU) in Portland on September 2 after being diagnosed with hemolytic uremic syndrome (HUS).*  While at OHSU, Ms. Wellborn required at least four blood transfusions and eight plasmapheresis exchanges.  She was discharged from OHSU on September 8, and continues her recovery at home.


“The FDA and the fresh produce industry have been working to resolve the issue of E. coli contamination for a number of years,” said William Marler, attorney for the Wellborns.  “It is unfortunate that outbreaks continue to happen and that consumers continue to be injured as a result.”

BACKGROUND:  Marler Clark has extensive experience representing victims of foodborne illnesses.  William Marler represented Brianne Kiner in her $15.6 million settlement with Jack in the Box in 1993.  In 1998, Marler Clark resolved Odwalla Juice E. coli outbreak cases for five families whose children developed HUS and were severely injured after consuming contaminated apple juice for a reported $12 million.  Mr. Marler recently resolved an HUS case for $11 million. 

Hemolytic Uremic Syndrome is a frightening illness that even in the best American medical facilities has a mortality rate of about 5%.  About 50% of patients require dialysis due to kidney failure, 25% experience seizures, and 5% suffer from diabetes mellitus.  The majority of HUS patients requires transfusion of blood products and develops complications common to the critically ill.  Among survivors of HUS, about five percent will eventually develop end stage kidney disease, with the resultant need for dialysis or transplantation, and another five to ten percent experience neurological or pancreatic problems which significantly impair quality of life.